Nath Bio-Genes shows potential in a growing sector, but faces challenges in profitability and valuation. Caution is advised.
Company’s Health51/100
Valuation
100/100 · PB 0.5122
Technical
Avoid
1M 2.329%
6M 9.15%
1Y -9.03%
Confidence100%
Low leverage (D/E)Reasonable PB valuation
Weak ROEPromoter pledge present